CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 46 filers reported holding CATALYST BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $30,000 | -28.6% | 45,915 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $42,000 | -77.8% | 45,915 | 0.0% | 0.00% | -80.0% |
| Q3 2021 | $189,000 | -34.4% | 45,915 | -30.9% | 0.01% | -44.4% |
| Q2 2021 | $288,000 | -16.5% | 66,425 | -2.9% | 0.01% | -30.8% |
| Q1 2021 | $345,000 | +48.1% | 68,425 | +72.1% | 0.01% | -18.8% |
| Q2 2020 | $233,000 | -65.1% | 39,750 | -30.4% | 0.02% | -72.4% |
| Q2 2018 | $667,000 | +4.9% | 57,144 | +131.8% | 0.06% | -22.7% |
| Q1 2018 | $636,000 | – | 24,652 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 66,951 | $13,859 | 0.01% |
| Colorado Capital Management, Inc. | 34,165 | $7 | 0.01% |
| Nantahala Capital Management | 160,430 | $33,209 | 0.00% |
| Kynam Capital Management, LP | 89,886 | $18,606 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $4,140 | 0.00% |
| MORGAN STANLEY | 38,404 | $7,950 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 259,467 | $52 | 0.00% |
| BlackRock Inc. | 169,904 | $35,170 | 0.00% |
| Bank of New York Mellon Corp | 200,638 | $41,532 | 0.00% |
| Citadel Advisors | 5,700 | $1,180 | 0.00% |